Anaptysbio ANAB
NASDAQ ANAB
$50.26 -0.11 (-0.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) Deferred Taxes (2025)

Updated

Anaptysbio (ANAB) recorded Deferred Taxes of -$3.54 million in Q1 2025.

Analysis

Anaptysbio (ANAB) Deferred Taxes (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -479.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -195.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Anaptysbio 1.46 Bn 349.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -3.54 Mn
API Access

Anaptysbio Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ANAB&period=max&api_key=YOUR_API_KEY